GlaxoSmithKline Plc agreed to pay about $60 million in the first settlements of lawsuits alleging the company’s Avandia diabetes drug causes heart attacks and strokes in some users, according to a Bloomberg report.
Glaxo agreed to resolve more than 700 Avandia suits filed by three attorneys, including Houston-based plaintiffs’ lawyer Mark Lanier and Philadelphia-based litigator Sol Weiss. The settlements come as Glaxo is set to face its first Avandia trial in state court in Philadelphia in July.
The company faces about 4,000 lawsuits that have been filed so far over the drug.
The company faces about 4,000 lawsuits that have been filed so far over the drug.
And people wonder why drugs cost so much.